Effectiveness of Baricitinib and Remdesivir in COVID-19 Treatment An early release, peer-reviewed clinical trial published by the National Institute of Health investigates the combination of baricitinib and remdesivir when used in people hospitalized with confirmed COVID-19 infection and shows promise Read More
Resource Allocation The National Academy of Medicine joined eight other national organizations in calling for governors, state health departments, and health system partners to prepare for implementation of crisis standards of care (CSC) during COVID-19 surge. The NAM recommendation comes Read More
COVID-19 Vaccines & Distribution Strategies As the nation prepare for the Phase 1a of the COVID-19 vaccine distribution plan, there is much conversation regarding who, when, and how this will be accomplished. In this early release article, the CDC states Read More
Multisystem Imaging Manifestations of COVID-19 In this article, authors discuss the effects of COVID-19 on multiple extrapulmonary systems. Widespread involvement of multiple body systems is attributed to the expression of ACE2 receptors in extrapulmonary tissues, resulting in direct tissue damage. Read More
CDC Recommendations for Holidays The Centers for Disease Control and Prevention has offered guidance for individuals and families preparing to celebrate fall and winter holidays.  This guidance is meant to supplement – not replace – any state, local, or other Read More
Cardiac Injury Prediction In COVID-19 Patients In this article from the International Journal of Cardiology, data from 124 consecutive hospitalized patients with COVID-19 were collected. The authors attempt to determine risk factors and predictive markers of cardiac injury in COVID-19 Read More
What Healthcare Professionals Need to Know about COVID-19 Vaccination Plans The CDC released this publication, which discusses “Operation Warp Speed”, the global race to produce a successful COVID-19 vaccination. With the likelihood of a vaccine being produced by the end Read More
Thromboprophylaxis treatment in critically ill COVID-19 patients In this article, a patient-tailored thromboprophylaxis protocol is discussed to reduce rates of venous and arterial thrombotic events related to COVID-19 in critically ill patients. Approximately 20-60% of critically ill COVID-19 patients have Read More
Clinical characteristics This cross-sectional study examined racial/ethnic variation in nasal gene expression of trans-membrane serine protease 2 (TMPRSS2). Within the 305 individuals with tissue samples (nasal epithelium collected during 2015-2018),  TMPRSS2 expression was significantly higher in Black individuals compared with Read More
RCT’s of therapeutic interventions against COVID-19 In this journal article, the authors discuss the challenges that plagued us during the early days of the COVID-19 pandemic. When the pandemic emerged, clinicians were faced with an unknown virus and had very Read More

Get Involved with Indiana CTSI